VRNA logo

Verona Pharma (VRNA) Depreciation and amortization

annual D&A:

$1.06M+$381.00K(+56.28%)
December 31, 2024

Summary

  • As of today (May 29, 2025), VRNA annual depreciation & amortization is $1.06 million, with the most recent change of +$381.00 thousand (+56.28%) on December 31, 2024.
  • During the last 3 years, VRNA annual D&A has risen by +$429.00 thousand (+68.20%).
  • VRNA annual D&A is now at all-time high.

Performance

VRNA Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAincome statement metrics

quarterly D&A:

$295.00K+$36.00K(+13.90%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VRNA quarterly depreciation & amortization is $295.00 thousand, with the most recent change of +$36.00 thousand (+13.90%) on March 31, 2025.
  • Over the past year, VRNA quarterly D&A has increased by +$32.00 thousand (+12.17%).
  • VRNA quarterly D&A is now at all-time high.

Performance

VRNA quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAincome statement metrics

TTM D&A:

$1.09M+$32.00K(+3.02%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VRNA TTM depreciation & amortization is $1.09 million, with the most recent change of +$32.00 thousand (+3.02%) on March 31, 2025.
  • Over the past year, VRNA TTM D&A has increased by +$307.00 thousand (+39.21%).
  • VRNA TTM D&A is now at all-time high.

Performance

VRNA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAincome statement metrics

VRNA Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.3%+12.2%+39.2%
3 y3 years+68.2%+81.0%+70.6%
5 y5 years+107.5%+84.4%+103.0%

VRNA Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+68.2%at high+95.4%at high+75.8%
5 y5-yearat high+107.5%at high+95.4%at high+103.0%
alltimeall timeat high>+9999.0%at high+1375.0%at high+5350.0%

VRNA Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$295.00K(+13.9%)
$1.09M(+3.0%)
Dec 2024
$1.06M(+56.3%)
$259.00K(-2.6%)
$1.06M(+5.1%)
Sep 2024
-
$266.00K(-1.5%)
$1.01M(+12.4%)
Jun 2024
-
$270.00K(+2.7%)
$896.00K(+14.4%)
Mar 2024
-
$263.00K(+26.4%)
$783.00K(+15.7%)
Dec 2023
$677.00K(+6.4%)
$208.00K(+34.2%)
$677.00K(+9.2%)
Sep 2023
-
$155.00K(-1.3%)
$620.00K(-0.3%)
Jun 2023
-
$157.00K(0.0%)
$622.00K(-1.3%)
Mar 2023
-
$157.00K(+4.0%)
$630.00K(-0.9%)
Dec 2022
$636.00K(+1.1%)
$151.00K(-3.8%)
$636.00K(-1.7%)
Sep 2022
-
$157.00K(-4.8%)
$647.00K(-0.8%)
Jun 2022
-
$165.00K(+1.2%)
$652.00K(+2.0%)
Mar 2022
-
$163.00K(+0.6%)
$639.00K(+1.6%)
Dec 2021
$629.00K(+1.0%)
$162.00K(0.0%)
$629.00K(+1.8%)
Sep 2021
-
$162.00K(+6.6%)
$618.00K(+0.8%)
Jun 2021
-
$152.00K(-0.7%)
$613.00K(-0.5%)
Mar 2021
-
$153.00K(+1.3%)
$616.00K(-1.1%)
Dec 2020
$623.00K(+22.2%)
$151.00K(-3.8%)
$623.00K(+16.0%)
Sep 2020
-
$157.00K(+1.3%)
$537.00K(-4.6%)
Jun 2020
-
$155.00K(-3.1%)
$562.70K(+4.8%)
Mar 2020
-
$160.00K(+146.2%)
$537.00K(+5.3%)
Dec 2019
$510.00K
$65.00K(-64.4%)
$510.00K(+7.3%)
DateAnnualQuarterlyTTM
Sep 2019
-
$182.70K(+41.3%)
$475.50K(+46.2%)
Jun 2019
-
$129.30K(-2.8%)
$325.20K(+44.5%)
Mar 2019
-
$133.00K(+336.1%)
$225.10K(+81.1%)
Dec 2018
$124.40K(-25.2%)
$30.50K(-5.9%)
$124.30K(-33.3%)
Sep 2018
-
$32.40K(+11.0%)
$186.30K(+2.4%)
Jun 2018
-
$29.20K(-9.3%)
$182.00K(+2.0%)
Mar 2018
-
$32.20K(-65.2%)
$178.40K(+7.3%)
Dec 2017
$166.20K(+117.3%)
$92.50K(+229.2%)
$166.20K(+125.5%)
Sep 2017
-
$28.10K(+9.8%)
$73.70K(+61.6%)
Jun 2017
-
$25.60K(+28.0%)
$45.60K(+128.0%)
Mar 2017
-
$20.00K
$20.00K
Dec 2016
$76.50K(-2.5%)
-
-
Dec 2015
$78.50K(-4.7%)
-
-
Dec 2014
$82.40K(+32.9%)
-
-
Dec 2013
$62.00K(+26.3%)
-
-
Dec 2012
$49.10K(+35.3%)
-
-
Dec 2011
$36.30K(+12.0%)
-
-
Dec 2010
$32.40K(-9.0%)
-
-
Dec 2009
$35.60K(+28.1%)
-
-
Dec 2008
$27.80K(+7.8%)
-
-
Dec 2007
$25.80K(+561.5%)
-
-
Dec 2006
$3900.00
-
-

FAQ

  • What is Verona Pharma annual depreciation & amortization?
  • What is the all time high annual D&A for Verona Pharma?
  • What is Verona Pharma annual D&A year-on-year change?
  • What is Verona Pharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Verona Pharma?
  • What is Verona Pharma quarterly D&A year-on-year change?
  • What is Verona Pharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for Verona Pharma?
  • What is Verona Pharma TTM D&A year-on-year change?

What is Verona Pharma annual depreciation & amortization?

The current annual D&A of VRNA is $1.06M

What is the all time high annual D&A for Verona Pharma?

Verona Pharma all-time high annual depreciation & amortization is $1.06M

What is Verona Pharma annual D&A year-on-year change?

Over the past year, VRNA annual depreciation & amortization has changed by +$381.00K (+56.28%)

What is Verona Pharma quarterly depreciation & amortization?

The current quarterly D&A of VRNA is $295.00K

What is the all time high quarterly D&A for Verona Pharma?

Verona Pharma all-time high quarterly depreciation & amortization is $295.00K

What is Verona Pharma quarterly D&A year-on-year change?

Over the past year, VRNA quarterly depreciation & amortization has changed by +$32.00K (+12.17%)

What is Verona Pharma TTM depreciation & amortization?

The current TTM D&A of VRNA is $1.09M

What is the all time high TTM D&A for Verona Pharma?

Verona Pharma all-time high TTM depreciation & amortization is $1.09M

What is Verona Pharma TTM D&A year-on-year change?

Over the past year, VRNA TTM depreciation & amortization has changed by +$307.00K (+39.21%)
On this page